Today the indication for palliative embolization of inoperable renal carcinoma is more restricted than several years ago. Reviewing 31 own palliative occlusions of the renal artery in 29 patients over a period of 5 1/2 years two main reasons for this attitude are presented: 1. Because of collateral or parasitic vascular supply of kidney tumors the occlusion of the renal arteries only results in a retarded tumor growth rate and does not seem to prolong patient survival. 2. the "postembolization syndrome" after tumor occlusion has a relatively high complication rate and lethality (20% serious side effects, 3% deaths directly related to embolization). Therefore embolization of inoperable renal carcinomas is justified only in patients whose remaining lifetime can be alleviated by this measure. Certain indications are: massive hematuria, severe local pain due to the tumor and life endangering endocrine tumor activity, e.g. hypercalcemia. Uncertain indications such as recurring but not perilous hematuria causing progressive anemia and refusal of tumor surgery should be carefully balanced against the hazards of embolization.

Download full-text PDF

Source

Publication Analysis

Top Keywords

embolization inoperable
8
inoperable renal
8
tumor
6
renal
5
[limitations hazards
4
hazards palliative
4
palliative renal
4
renal tumor
4
tumor embolization]
4
embolization] today
4

Similar Publications

Idarubicin-loaded degradable hydrogel for TACE therapy enhances anti-tumor immunity in hepatocellular carcinoma.

Mater Today Bio

December 2024

Department of Interventional Oncology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou 510080, China.

Hepatocellular carcinoma (HCC) is a common and deadly cancer, often diagnosed at advanced stages, limiting surgical options. Transcatheter arterial chemoembolization (TACE) is a primary treatment for inoperable and involves the use of drug-eluting microspheres to slowly release chemotherapy drugs. However, patient responses to TACE vary, with some experiencing tumor progression and recurrence.

View Article and Find Full Text PDF

Intratumoral pseudoaneurysm in a carotid body tumor.

Surg Neurol Int

November 2024

Department of Interventional Neuroradiology, Houston Methodist Hospital, Houston, Texas, United States.

Background: The occurrence of secondary vascular pathology in paragangliomas is extremely rare, particularly in carotid body tumors (CBTs).

Case Description: A 73-year-old female presented with computed tomography angiography revealing a right CBT with a large intratumoral contrast collection. Digital subtraction angiography confirmed a CBT with an internal carotid artery (ICA) intratumoral pseudoaneurysm.

View Article and Find Full Text PDF

Ethanol Chemical Gallbladder Ablation for Cholecystitis in Inoperable Elderly Patients.

Cardiovasc Intervent Radiol

November 2024

Service de Radiologie Interventionnelle, Centre Hospitalier Sud Francilien, 40 Avenue Serge Dassault, 91100, Corbeil-Essonnes, France.

Purpose: Cholecystitis presents significant treatment challenges, especially in elderly patients with high surgical or anesthetic risks. While cholecystectomy remains the standard intervention, its feasibility is sometimes limited, leading to reliance on cholecystostomy, which has a high recurrence rate and does not address the underlying cause. The aim was to evaluate the efficacy and safety of chemical gallbladder ablation as a minimally invasive treatment option for acute cholecystitis in elderly and comorbid patients.

View Article and Find Full Text PDF

Anticoagulation management in gynecologic brachytherapy patients with perioperative or chronic thromboembolic disease: A retrospective analysis.

Brachytherapy

November 2024

Department of Radiation Medicine, Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Medical University of South Carolina, Charleston, SC. Electronic address:

Article Synopsis
  • The study focuses on women on chronic anticoagulation (AC) who need operative brachytherapy for gynecologic cancers, highlighting the lack of guidelines for their management during procedures.
  • Researchers analyzed data from 304 patients, finding that 10% were on chronic AC, primarily for venous thromboembolism or atrial fibrillation, with the most common cancers being cervical and inoperable uterine cancer.
  • The results showed a low rate of significant bleeding and no new embolic events, suggesting that these women can safely undergo brachytherapy without being excluded from the treatment.
View Article and Find Full Text PDF

Background/aim: Transileocolic portal vein embolization (TIPE) may reduce the risk of liver failure after massive hepatectomy. However, convincing evidence of its usefulness in this regard is yet to be reported. Therefore, this study aimed to investigate the use of TIPE after massive hepatectomy.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!